Stockscreener 앱 받기
0.2752
4.80%
0.0126
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Enterprise value to EBITDA forward of Medicus Pharma Ltd. – BOATS:MDCX - TradingView
Medicus Pharma Share PriceMDCX, RNS News, Articles, Quotes, & Charts (NASDAQ:MDCX) - Proactive financial news
Medicus Pharma cleared by FDA for registrational Phase 2b trial in patients with Gorlin Syndrome - Proactive financial news
Small cap wrap: Nextsource Materials, First Phosphate, Medicus Pharma, Nextech3D.ai… - Proactive financial news
FDA clears Medicus Pharma to start Phase 2b tri... - Pluang
Medicus Pharma Ltd (MDCX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medicus Pharma receives FDA clearance to begin registrational SkinJect study for Gorlin syndrome - Yahoo Finance
FDA clears Medicus Pharma to start pivotal SkinJect trial for Gorlin Syndrome skin cancer treatment - Pluang
FDA clears Medicus Pharma Gorlin Syndrome study to proceed - Investing.com
Medicus Pharma Receives FDA “Study May Proceed” Letter for - GlobeNewswire
Medicus Pharma Ltd (MDCX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Medicus Pharma Ltd (MDCX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Medicus Pharma Ltd. Revenue Breakdown – NASDAQ:MDCXW - TradingView
Medicus Pharma Ltd (MDCX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings - Moomoo
MDCX|Medicus Pharma Ltd|Price:0.370|Chg%:-0.014 - TradingKey
TradingKey - TradingKey
Medicus Pharma Ltd (MDCX) Institutional Confidence - TradingKey
Medicus Pharma Ltd. Revenue Breakdown – NASDAQ:MDCX - TradingView
MDCX|Medicus Pharma Ltd|Price:0.303|Chg%:-0.015 - TradingKey
ICYMI: Medicus Advances Leaner Teverelix Trial After FDA Review - MyChesCo
Medicus Pharma Ltd. (MDCX) Declines 7.39% as Stock Approaches Key Support at $0.36WMA Signal - dars.gov.et
Medicus Pharma CEO details Teverelix progress – ICYMI - Proactive financial news
Medicus Cuts Planned Teverelix Trial Enrollment by Two-Thirds - MyChesCo
Medicus Pharma advances Phase 2 study following FDA and IRB feedback - Proactive financial news
Medicus Pharma (MDCX) Receives FDA Feedback for Clinical Study - GuruFocus
Medicus Pharma wins FDA backing for optimized Phase 2 Teverelix study in acute urinary retention - Bitget
Medicus Pharma redesigns Phase 2 trial for 126 patients - grafa.com
Medicus Pharma receives FDA feedback for optimized Phase 2 study By Investing.com - Investing.com Nigeria
Medicus Pharma receives FDA feedback for optimized Phase 2 study - Investing.com
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention - The Manila Times
Medicus Pharma Receives Positive FDA Feedback and Central - GlobeNewswire
Medicus Pharma (MDCX) Stock Forum and Discussion - Moomoo
Medicus Pharma advances Teverelix Phase 2 study after FDA feedback, IRB approval - Proactive financial news
Medicus Pharma Expects About 126 Patients in Redesigned Teverelix Study - Stock Titan
Medicus Pharma on Bloomberg World - Independent Mail
Number of shareholders of Medicus Pharma Ltd. – NASDAQ:MDCX - TradingView
Number of shareholders of Medicus Pharma Ltd. – BOATS:MDCX - TradingView
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Medicus Pharma Ltd. (MDCX) Slips 3.5% as Stock Nears Critical Support LevelIndex Put Call - DonanımHaber
Enterprise value to revenue forward of Medicus Pharma Ltd. – BOATS:MDCXW - TradingView
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - MPNnow.com
Enterprise value to EBIT forward of Medicus Pharma Ltd. – BOATS:MDCXW - TradingView
Price to sales forward of Medicus Pharma Ltd. – BOATS:MDCXW - TradingView
Enterprise value to EBITDA forward of Medicus Pharma Ltd. – BOATS:MDCXW - TradingView
MDCX Stock Price, Quote & Chart - ChartMill
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - The Poughkeepsie Journal
MDCXMedicus Pharma Ltd Revenue Breakdown - Finviz
MDCX Q1 2026 Earnings: Wider-than-expected loss as clinical programs advanceEarnings Outlook Update - dars.gov.et
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group - Voice of Alexandria
Medicus Pharma (MDCX) Stock Analysis Report | Financials & Insights - Benzinga España
Medicus Pharma Ltd. (MDCX) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Pipeline ProgressTangible Book Value - dars.gov.et
Medicus Pharma Warrants (MDCXW) Rally 4.6% as Buyers Defend SupportCall Resistance - dars.gov.et
Medicus Pharma Seeks Rare Pediatric Disease Designation for SkinJect Patch in Gorlin SyndromeRevenue Inflection Point - dars.gov.et
Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology? - Insider Monkey
Medicus Pharma Ltd Actuals & Estimates (NASDAQ:MDCX) - TradingView
0.48%
0.82%
자본화:
|
볼륨(24시간):